iifl-logo

Apollo Hospitals Enterprise Ltd Company Summary

Add as a Preferred Source on Google
7,068
(-0.08%)
Dec 24, 2025|09:19:59 AM

Apollo Hospitals Enterprise Ltd Summary

Apollo Hospitals Enterprise Ltd is the largest private hospital chain in India and houses hospitals, pharmacies, diagnostic clinics, telehealth, digital care, etc. within its enterprise footprint. The equity is well traded at the National Stock Exchange and has a very good market capitalisation, indicating good investor interest in the healthcare sector.

Company Overview

Founded in 1983 by Dr. Prathap C. Reddy, the healthcare network began its journey in Chennai as India’s first corporate hospital and has grown to establish itself throughout the country. It continued to focus on its premium quality of care, working through accredited facilities and a rapidly expanding proprietary digital platform that broadens access beyond the hospital.

Founding & Evolution

  • Founded: 1983 by Dr. Prathap C. Reddy in Chennai.
  • Listed year: 1996 (NSE listing date 10 Jan 1996).
  • Leadership: Founder-Chairman Dr. Prathap C. Reddy; senior executives include Vice Chairperson and Joint Managing Director roles overseeing core businesses.
  • Strategic Acquisitions & Alliances: Apollo Hospitals Enterprise Ltd acquired IFC’s 31% AHLL stake for ₹1,254 crore, partnered with Hackensack Meridian Health.

Scale and Presence

Apollo operates owned and managed hospitals along with pharmacies, diagnostics, clinics, and digital care services. These centres address patient needs across the continuum of care. Its hospital-led network is supported by Apollo HealthCo and Apollo Health & Lifestyle. They together extend reach into retail pharmacy, primary care, and diagnostics nationwide.

  • Branches/sites: 71 owned and managed hospitals across India.
  • Employees: A large, multi‑disciplinary workforce of 83,147 employees across clinical and support functions.
  • International operations: Select overseas presence and global academic collaborations, including programs with Health Education England and Macquarie University.
  • Customer base: Serves patients across India with growing access via telemedicine and the Apollo 24/7 platform.

Business Segments

  • Hospitals and clinics (acute and specialty care).
  • Pharmacies via Apollo HealthCo (India’s largest retail pharmacy chain).
  • Diagnostics and day‑care under Apollo Health & Lifestyle.
  • Digital health via Apollo 24/7.

Growth has been driven by continued acquisitions and alliances that improve regional coverage and expand into adjacent services. The group has also exited non-core assets. It has streamlined joint ventures to give more focus on integrated healthcare delivery.

  • 2014: Acquired Hetero Med Solutions pharmacy chain; stores rebranded as Apollo Pharmacy.
  • 2020: Sold majority stake in Apollo Munich Health Insurance to HDFC; reinvested in core healthcare.
  • 2020: Acquired partner’s 50% JV stake in Apollo Gleneagles Hospital, Kolkata.
  • Academic MoUs: Health Education England and Macquarie University for training and rotations.

ESG & Sustainability Focus

Access and inclusion have been advanced through telemedicine and Apollo 24/7, alongside workforce development via Apollo Medskills and research initiatives through Apollo Research and Innovations.

  • Quality accreditations (JCI, NABH) underpin clinical systems and outcomes.
  • Digital access and telehealth at scale via Apollo 24/7.
  • Workforce and research investments (Apollo Medskills; Apollo Research and Innovations).

Leadership Table

Name Designation
Dr. Prathap C. Reddy Founder-Chairman
Dr. Preetha Reddy Vice Chairperson
Suneeta Reddy Managing Director
Dr. Sangita Reddy Joint Managing Director

Top Mutual Funds Invested in Apollo Hospitals Enterprise Ltd Share (As on 31st October 2025)

Fund Name AUM (%)
SBI Nifty 50 ETF 0.66
Axis Large Cap Fund-Reg(G) 2.24
Invesco India Contra Fund-Reg(G) 2.71
Mirae Asset Large Cap Fund-Reg(G) 1.28
Axis Focused Fund-Reg(G) 4.08
HDFC Flexi Cap Fund(G) 0.55
Nippon India Pharma Fund(G) 5.97
Franklin India Flexi Cap Fund(G) 2.30
Kotak Arbitrage Fund(G) 0.62
UTI Nifty 50 ETF 0.66
Axis ELSS Tax Saver Fund-Reg(G) 1.08
Mirae Asset Large & Midcap Fund-Reg(G) 0.87
Nippon India ETF Nifty 50 BeES 0.66
Aditya Birla SL Flexi Cap Fund(G) 1.42
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.